TWC
HELP

TD Waterhouse Canada’s Helus Pharma Inc. Common Stock HELP Stock Holding History

TD Waterhouse Canada’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$521 Sell
83
-34
-29% -$170 ﹤0.01% 2246
2026
Q1 		$580 Sell
117
-1,916
-94% -$12.4K ﹤0.01% 2139
2025
Q4 		$16.4K Sell
2,033
-720
-26% -$4.63K ﹤0.01% 1435
2025
Q3 		$16.4K Hold
2,753
– – ﹤0.01% 1431
2025
Q2 		$24.7K Hold
2,753
– – ﹤0.01% 1277
2025
Q1 		$16.2K Hold
2,753
– – ﹤0.01% 1306
2024
Q4 		$24.3K Hold
2,753
– – ﹤0.01% 1239
2024
Q3 		$23.9K Sell
2,753
-10
-0.4% -$99 ﹤0.01% 1202
2024
Q2 		$28.2K Sell
2,763
-132
-5% -$1.73K ﹤0.01% 1151
2024
Q1 		$60.5K Buy
2,895
+1,755
+154% +$25.4K ﹤0.01% 1000
2023
Q4 		$21.9K Hold
1,140
– – ﹤0.01% 1114
2023
Q3 		$33.3K Hold
1,140
– – ﹤0.01% 1002
2023
Q2 		$25.1K Buy
1,140
+140
+14% +$1.68K ﹤0.01% 1081
2023
Q1 		$18.7K Buy
1,000
+934
+1,415% +$15.1K ﹤0.01% 1114
2022
Q4 		$758 Hold
66
– – ﹤0.01% 1582
2022
Q3 		$1.44K Buy
+66
New +$1.79K ﹤0.01% 1540
2022
Q2 		– Sell
-45
Closed -$1.84K – 1756
2022
Q1 		$1.84K Buy
45
+26
+137% +$950 ﹤0.01% 1608
2021
Q4 		$1.11K Buy
+19
New +$1.2K ﹤0.01% 1646

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

TD Waterhouse Canada's HELP Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Helus Pharma Inc. Common Stock (HELP) stake by 29% in Q2 2026, selling an estimated $170 and leaving 83 shares worth $521. The position accounts for ﹤0.01% of the portfolio, ranked #2246.

TD Waterhouse Canada first reported a position in HELP in Q4 2021 and has held it in 18 quarters since. The position peaked at $60.5K in Q1 2024. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • TD Waterhouse Canada held 83 shares of Helus Pharma Inc. Common Stock worth $521 as of Q2 2026.
  • TD Waterhouse Canada sold 34 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $170.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2246 holding.
  • TD Waterhouse Canada first reported a position in Helus Pharma Inc. Common Stock in Q4 2021 and has held it in 18 quarters since.
  • TD Waterhouse Canada's Helus Pharma Inc. Common Stock position peaked at $60.5K in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.